Druggio

AstraZeneca

AstraZeneca is a pharmaceutical company that focuses on developing and commercializing innovative drugs for the treatment of a wide range of diseases. They work in areas such as oncology, cardiovascular, renal and metabolism, and respiratory diseases. Some of their notable drugs include Tagrisso for lung cancer, Brilinta for heart disease, and Farxiga for diabetes. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC.

AstraZeneca's Drugs

Made by

Approval date

2021/9/27

Treats

Systemic lupus erythematosus

Made by

Approval date

2021/5/21

Treats

Made by

Approval date

2021/1/22

Treats

Chronic lymphocytic leukemia

Made by

Approval date

2020/3/25

Made by

Approval date

2018/7/2

Treats

Small cell lung cancer Non-small cell lung cancer

Made by

Approval date

2018/1/19

Treats

Breast cancer Prostate cancer Ovarian cancer Pancreatic cancer

Made by

Approval date

2018/1/19

Treats

Made by

Approval date

2016/9/28

Made by

Approval date

2016/3/28

Treats

Non-small cell lung cancer

Made by

Approval date

2015/9/28

Treats

Medullary thyroid cancer

Made by

Approval date

2011/9/26

Treats

Made by

Approval date

2011/7/1

Treats

Zollinger-Ellison syndrome Helicobacter pylori infection Peptic ulcer Gastroesophageal reflux disease

Made by

Approval date

2005/1/19

Treats

Familial hypercholesterolemia, Autosomal dominant hypercholesterolaemia Hyperlipidemia

Made by

Approval date

2002/7/5

Treats

Non-small cell lung cancer

Made by

Approval date

2001/6/20

Made by

Approval date

2001/4/4

Treats

Zollinger-Ellison syndrome Peptic ulcer

Made by

Approval date

2001/4/4

Made by

Approval date

2000/12/22

Treats

Made by

Approval date

2000/12/22

Made by

Approval date

2000/12/12

Treats

Bipolar disorder, Manic depressive illness Schizophrenia

Made by

Approval date

2000/1/18